FPHAX vs. PPH
Compare and contrast key facts about Fidelity Select Pharmaceuticals Portfolio (FPHAX) and VanEck Vectors Pharmaceutical ETF (PPH).
FPHAX is managed by Fidelity. It was launched on Jun 17, 2001. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FPHAX or PPH.
Performance
FPHAX vs. PPH - Performance Comparison
Returns By Period
In the year-to-date period, FPHAX achieves a 10.38% return, which is significantly higher than PPH's 7.57% return. Over the past 10 years, FPHAX has underperformed PPH with an annualized return of 3.06%, while PPH has yielded a comparatively higher 4.82% annualized return.
FPHAX
10.38%
-12.39%
-7.31%
15.38%
4.10%
3.06%
PPH
7.57%
-8.85%
-3.66%
13.59%
9.22%
4.82%
Key characteristics
| FPHAX | PPH | |
|---|---|---|
| Sharpe Ratio | 1.05 | 1.33 |
| Sortino Ratio | 1.53 | 1.89 |
| Omega Ratio | 1.19 | 1.24 |
| Calmar Ratio | 0.95 | 1.12 |
| Martin Ratio | 3.99 | 4.48 |
| Ulcer Index | 4.20% | 3.21% |
| Daily Std Dev | 15.93% | 10.82% |
| Max Drawdown | -37.34% | -46.49% |
| Current Drawdown | -17.64% | -12.84% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FPHAX vs. PPH - Expense Ratio Comparison
FPHAX has a 0.75% expense ratio, which is higher than PPH's 0.36% expense ratio.
Correlation
The correlation between FPHAX and PPH is 0.88, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
FPHAX vs. PPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FPHAX vs. PPH - Dividend Comparison
FPHAX's dividend yield for the trailing twelve months is around 0.77%, less than PPH's 1.86% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.77% | 0.63% | 1.33% | 1.17% | 1.31% | 1.31% | 1.44% | 1.33% | 1.07% | 5.59% | 5.81% | 11.12% |
PPH VanEck Vectors Pharmaceutical ETF | 1.86% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
Drawdowns
FPHAX vs. PPH - Drawdown Comparison
The maximum FPHAX drawdown since its inception was -37.34%, smaller than the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for FPHAX and PPH. For additional features, visit the drawdowns tool.
Volatility
FPHAX vs. PPH - Volatility Comparison
Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 5.80% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 3.79%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.